Kotwal Prakash P, Ansari Mohammed Tahir, Mahmood Asjad, Gupta Vikas, Khan Shah Alam
Institute of Orthopaedics and Joint Replacement, Pushpawati Singhania Research Institute, Delhi, India.
Department of Orthopaedics, All India Institute of Medical Sciences, Delhi, India.
J Clin Orthop Trauma. 2020 Jul-Aug;11(4):657-661. doi: 10.1016/j.jcot.2020.05.032. Epub 2020 Jun 9.
Primary giant cell tumor (GCT) arising from bones of hand are rare to occur. Metacarpals are often the most common site of involvement among hand bones. There are no uniform guidelines for treatment of GCT involving metacarpals due to lack of relevant literature.
To suggest a management strategy for GCT involving metacarpals.
Retrospective review of cases of GCT involving metacarpals over a period of 15 years from 2005 to 2019 managed at department of Orthopaedics, All India Institute of Medical Sciences, New Delhi.
A total of 12 cases of GCT involving metacarpal were included, out of which one was lost to follow-up. Four cases were recurrent, and seven were primary at the time of surgery. All the patients were operated with wide excision of the tumor. In seven patients reconstruction of the metacarpal and MCPJ was done using fibular strut graft and silastic artificial joint, while in two patients, MCPJ arthrodesis was performed using fibula and/or iliac crest bone graft. In another two patients, the MCPJ was reconstructed using reversed vascularised toe transfer. Mean follow up of the patients was 3.22 ± 2.07 years. Mean Quick DASH score at latest follow-up of patients operated with silastic joint reconstruction, reversed vascularised toe transfer and arthrodesis of MCP joints were 30.5 ± 9.5, 25 ± 2.3 and 39.8 ± 3.4 respectively. Local recurrence occurred only in one patient at one year after surgery. All the patients were pain free at latest follow-up with quite functional and cosmetically acceptable hand.
Reversed vascularised metatarsal transfer has obtained better functional results compared to reconstruction with fibular grafting and silicone joint replacement but due to technical difficulties, vascularised joint transfer may not be performed in every setting and there is risk of donor site morbidities with this technique. Our strategy for the treatment of GCT involving metacarpal was to do vascularised joint transfer or arthrodesis for border digits and reconstruction with silicone joint for central digits.
原发性手部骨巨细胞瘤(GCT)较为罕见。掌骨是手部骨骼中最常受累的部位。由于缺乏相关文献,对于累及掌骨的GCT尚无统一的治疗指南。
提出一种针对累及掌骨的GCT的治疗策略。
回顾性分析2005年至2019年期间在新德里全印度医学科学研究所骨科接受治疗的15年间累及掌骨的GCT病例。
共纳入12例累及掌骨的GCT病例,其中1例失访。4例为复发性病例,7例在手术时为原发性病例。所有患者均接受了肿瘤广泛切除手术。7例患者采用腓骨支撑植骨和硅橡胶人工关节重建掌骨和掌指关节(MCPJ),2例患者采用腓骨和/或髂嵴骨移植进行MCPJ关节融合术。另外2例患者采用逆行带血管蒂趾移植重建MCPJ。患者的平均随访时间为3.22±2.07年。接受硅橡胶关节重建、逆行带血管蒂趾移植和MCP关节融合术的患者在最近一次随访时的平均Quick DASH评分分别为30.5±9.5、25±2.3和39.8±3.4。仅1例患者在术后1年出现局部复发。所有患者在最近一次随访时均无疼痛,手部功能良好且外观可接受。
与腓骨移植和硅胶关节置换重建相比,逆行带血管蒂跖骨移植获得了更好的功能结果,但由于技术困难,并非在所有情况下都能进行带血管蒂关节移植,且该技术存在供区并发症的风险。我们治疗累及掌骨的GCT的策略是,对于边缘手指进行带血管蒂关节移植或关节融合术,对于中间手指采用硅胶关节重建。